Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGγ-proteasome pathway

被引:255
作者
Li, Xiaotao
Amazit, Larbi
Long, Weiwen
Lonard, David M.
Monaco, John J.
O'Malley, Bert W.
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.molcel.2007.05.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously demonstrated that the proteasome activator REG gamma directs degradation of the steroid receptor coactivator SRC-3 by the 20S proteasome in an ATP- and ubiquitin-independent manner. Our efforts to identify additional endogenous direct targets of the REG gamma proteasome revealed that p21(Waf/Cip1), a central cyclin-dependent kinase inhibitor, is another endogenous target. Gain-of-function analysis, RNAi knockdown, REG gamma-deficient MEF analysis, and pulse-chase experiments substantiate that REG gamma promotes degradation of unbound p21. Cell-free proteasome proteolysis assays using purified REG gamma, p21, and the 20S proteasome confirm that REG gamma directly mediates degradation of free p21 in an ATP-and ubiquitin-independent manner. Depletion of REG gamma in a thyroid carcinoma cell line results in cell-cycle and proliferative alterations. Our study reveals that, in addition to degrading the SRC-3 growth coactivator, REG gamma also has a role in the regulation of the cell cycle through its ability to influence the level of a cell-cycle regulator(s).
引用
收藏
页码:831 / 842
页数:12
相关论文
共 38 条
[1]   A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 [J].
Asher, G ;
Tsvetkov, P ;
Kahana, C ;
Shaul, Y .
GENES & DEVELOPMENT, 2005, 19 (03) :316-321
[2]   Immune defects in 28-kDa proteasome activator γ-deficient mice [J].
Barton, LF ;
Runnels, HA ;
Schell, TD ;
Cho, YJ ;
Gibbons, R ;
Tevethia, SS ;
Deepe, GS ;
Monaco, JJ .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3948-3954
[3]  
Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001
[4]   Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation [J].
Bloom, J ;
Amador, V ;
Bartolini, F ;
DeMartino, G ;
Pagano, M .
CELL, 2003, 115 (01) :71-82
[5]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[6]   Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes [J].
Cascio, P ;
Call, M ;
Petre, BM ;
Walz, T ;
Goldberg, AL .
EMBO JOURNAL, 2002, 21 (11) :2636-2645
[7]   p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells [J].
Cayrol, C ;
Knibiehler, M ;
Ducommun, B .
ONCOGENE, 1998, 16 (03) :311-320
[8]   N-acetylation and ubiquitin-independent proteasomal degradation of p21Cip1 [J].
Chen, XY ;
Chi, Y ;
Bloecher, A ;
Aebersold, R ;
Clurman, BE ;
Roberts, JM .
MOLECULAR CELL, 2004, 16 (05) :839-847
[9]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[10]   Absence of the steroid receptor coactivator-3 induces B-cell lymphoma [J].
Coste, Agnes ;
Antal, Maria Cristina ;
Chan, Susan ;
Kastner, Philippe ;
Mark, Manuel ;
O'Malley, Bert W. ;
Auwerx, Johan .
EMBO JOURNAL, 2006, 25 (11) :2453-2464